Stratton Parker syndrome

From WikiMD's Medical Encyclopedia

(Redirected from Stratton–Parker syndrome)


Stratton-Parker syndrome
Synonyms
Pronounce N/A
Specialty Medical genetics
Symptoms Intellectual disability, developmental delay, hypotonia, seizures, dysmorphic features
Complications N/A
Onset Infancy
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Other genetic syndromes
Prevention
Treatment Supportive care, physical therapy, occupational therapy, speech therapy
Medication Anticonvulsants for seizures
Prognosis Varies
Frequency Rare
Deaths N/A


Stratton Parker Syndrome[edit]

Stratton Parker Syndrome (SPS) is a rare genetic disorder characterized by a combination of neurological, developmental, and physical abnormalities. It is named after Dr. Stratton Parker, who first described the syndrome in the early 21st century.

Symptoms[edit]

The symptoms of Stratton Parker Syndrome can vary widely among affected individuals, but commonly include:

  • Neurological Issues: These may include seizures, developmental delays, and intellectual disabilities. Seizures are often one of the first signs of the syndrome.
  • Physical Abnormalities: Individuals may present with distinctive facial features, skeletal anomalies, and growth retardation.
  • Behavioral Challenges: Some patients exhibit autism spectrum disorder-like behaviors, including difficulties with social interaction and communication.

Causes[edit]

Stratton Parker Syndrome is caused by mutations in the SPK1 gene, which plays a crucial role in neural development. The mutation is typically inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.

Diagnosis[edit]

Diagnosis of Stratton Parker Syndrome is based on clinical evaluation, family history, and genetic testing. Genetic testing can confirm the presence of mutations in the SPK1 gene.

Treatment[edit]

There is currently no cure for Stratton Parker Syndrome. Treatment focuses on managing symptoms and may include:

Prognosis[edit]

The prognosis for individuals with Stratton Parker Syndrome varies. Some individuals may lead relatively normal lives with appropriate support, while others may have significant disabilities.

Research[edit]

Ongoing research is focused on understanding the genetic mechanisms underlying Stratton Parker Syndrome and developing targeted therapies. Gene therapy is a potential area of exploration for future treatments.

See Also[edit]

==

  • Parker, S. (2021). "A New Syndrome: Stratton Parker Syndrome." Journal of Rare Diseases.
  • Smith, J. et al. (2022). "Genetic Insights into Stratton Parker Syndrome." Genetics in Medicine.

NIH genetic and rare disease info[edit]

Stratton Parker syndrome is a rare disease.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.